The IGF1/IGF-1R signaling axis was also shown to promote the survival of dormant pancreatic cancer cells after oncogenic KRAS or MYC ablation in pancreatic cancer cells [78]. The gene discussed is IGF1R; the disease is pancreatic neoplasm.